(Q37046164)

17 August 2017

1 reference

title

A new challenge for Europe: introducing a pediatric quadrivalent vaccine for measles, mumps, rubella, and varicella (English)

1 reference

17 August 2017

1 reference

1 reference

1 reference

José Ramet

1

1 reference

17 August 2017

publication date

1 November 2007

1 reference

International Journal of Infectious Diseases

17 August 2017

published in

1 reference

17 August 2017

volume

11 Suppl 2

1 reference

17 August 2017

page(s)

S49-55

1 reference

Severe complications associated with varicella: Province of Quebec, April 1994 to March 1996

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960022-8

7 January 2021

Consensus: varicella vaccination of healthy children--a challenge for Europe

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960022-8

7 January 2021

Varicella mortality: trends before vaccine licensure in the United States, 1970-1994

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960022-8

7 January 2021

Varicella-zoster virus epidemiology--a changing scene?

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960022-8

7 January 2021

Effectiveness over time of varicella vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960022-8

7 January 2021

Decline in mortality due to varicella after implementation of varicella vaccination in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960022-8

7 January 2021

Varicella disease after introduction of varicella vaccine in the United States, 1995-2000

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960022-8

7 January 2021

The value of varicella vaccination in healthy children: cost-benefit analysis of the situation in France

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960022-8

7 January 2021

Decline in varicella-related hospitalizations and expenditures for children and adults after introduction of varicella vaccine in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960022-8

7 January 2021

A combination measles, mumps, rubella, and varicella vaccine (ProQuad) given to 4- to 6-year-old healthy children vaccinated previously with M-M-RII and Varivax

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960022-8

7 January 2021

Safety and immunogenicity of a measles, mumps, rubella and varicella vaccine given with combined Haemophilus influenzae type b conjugate/hepatitis B vaccines and combined diphtheria-tetanus-acellular pertussis vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960022-8

7 January 2021

Varicella in non-immune persons: incidence, hospitalization and mortality rates

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960022-8

7 January 2021

The seroepidemiology of varicella in Italy

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960022-8

7 January 2021

Empirical data on the varicella situation in Germany for vaccination decisions

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960022-8

7 January 2021

Epidemiology of severe varicella-zoster virus infection in Spain

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960022-8

7 January 2021

Seroepidemiology of varicella-zoster virus infection in Catalonia (Spain). Rationale for universal vaccination programmes

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960022-8

7 January 2021

Deaths from chickenpox in England and Wales 1995-7: analysis of routine mortality data

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960022-8

7 January 2021

Varicella-zoster virus infection in Australia

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960022-8

7 January 2021

Uptake of varicella vaccine--a cross sectional survey of parental attitudes to nationally recommended but unfunded varicella immunisation.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960022-8

7 January 2021

Potentially lethal bacterial infection associated with varicella zoster virus

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960022-8

7 January 2021

Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960022-8

7 January 2021

Review of management of purpura fulminans and two case reports.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960022-8

7 January 2021

Theoretical epidemiologic and morbidity effects of routine varicella immunization of preschool children in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960022-8

7 January 2021

Epidemiology and economic impact of varicella in immunocompetent children in Spain. A nation-wide study.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960022-8

7 January 2021

The cost-effectiveness of varicella vaccine programs for Australia.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960022-8

7 January 2021

The cost-effectiveness of varicella vaccination in Canada

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960022-8

7 January 2021

Uptake of varicella vaccination among young children in the United States: a success story in eliminating racial and ethnic disparities

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960022-8

7 January 2021

Varicella: a vaccine preventable disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960022-8

7 January 2021

Measles, mumps, rubella, and varicella combination vaccine: safety and immunogenicity alone and in combination with other vaccines given to children. Measles, Mumps, Rubella, Varicella Vaccine Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960022-8

7 January 2021

The safety and immunogenicity of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children: a study of manufacturing consistency and persistence of antibody.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960022-8

7 January 2021

Evaluation of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960022-8

7 January 2021

Varicella-zoster vaccine in the USA: success for control of disease severity, but what next?

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960022-8

7 January 2021

Ten year follow-up of healthy children who received one or two injections of varicella vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960022-8

7 January 2021

10.1016/S1201-9712(07)60022-8

Identifiers

DOI

1 reference

17 August 2017

1 reference